Advocacy at a Glance 2/14/20 Advocacy at a Glance 2/14/20 Advocacy at a Glance Read More 2/11/20 2/11/20 Alliance Issues Analysis of President's FY 21 Request for FDA Funding Read More Analysis and Commentary 2/7/20 Analysis and Commentary 2/7/20 Shuren Fills Alliance in on Fast-Moving Science and CDRH Needs Read More Advocacy at a Glance 2/7/20 Advocacy at a Glance 2/7/20 Advocacy at a Glance Read More Analysis and Commentary 2/1/20 Analysis and Commentary 2/1/20 FDA's FY 21 Appropriation: What's Happening When? Read More Advocacy at a Glance 2/1/20 Advocacy at a Glance 2/1/20 Advocacy at a Glance Read More Analysis and Commentary 1/25/20 Analysis and Commentary 1/25/20 Alliance Learns About CBER Priorities for 2020 and Beyond Read More Advocacy at a Glance 1/25/20 Advocacy at a Glance 1/25/20 Advocacy at a Glance Read More Analysis and Commentary 1/17/20 Analysis and Commentary 1/17/20 Hill Day and Other Upcoming Alliance Advocacy Initiatives Read More Advocacy at a Glance 1/17/20 Advocacy at a Glance 1/17/20 Advocacy at a Glance Read More Analysis and Commentary 1/10/20 Analysis and Commentary 1/10/20 FDA Is Its People Read More Advocacy at a Glance 1/10/20 Advocacy at a Glance 1/10/20 Advocacy at a Glance Read More Analysis and Commentary 12/20/19 Analysis and Commentary 12/20/19 Success Again in 2019 ... Building Support for 2020 Read More Advocacy at a Glance 12/20/19 Advocacy at a Glance 12/20/19 Advocacy at a Glance Read More Analysis and Commentary 12/16/19 Analysis and Commentary 12/16/19 FDA's "Appropriation Fate" Is Evaluated on a Daily Basis Read More Advocacy at a Glance 12/16/19 Advocacy at a Glance 12/16/19 Advocacy at a Glance Read More Analysis and Commentary 12/8/19 Analysis and Commentary 12/8/19 Three Key Questions ... and the Answers Read More Advocacy at a Glance 12/8/19 Advocacy at a Glance 12/8/19 Advocacy at a Glance Read More Analysis and Commentary 11/22/19 Analysis and Commentary 11/22/19 Time to Talk Turkey ... Once Again Read More Advocacy at a Glance 11/22/19 Advocacy at a Glance 11/22/19 Advocacy at a Glance Read More Newer Posts Older Posts
Analysis and Commentary 2/7/20 Analysis and Commentary 2/7/20 Shuren Fills Alliance in on Fast-Moving Science and CDRH Needs Read More
Analysis and Commentary 2/1/20 Analysis and Commentary 2/1/20 FDA's FY 21 Appropriation: What's Happening When? Read More
Analysis and Commentary 1/25/20 Analysis and Commentary 1/25/20 Alliance Learns About CBER Priorities for 2020 and Beyond Read More
Analysis and Commentary 1/17/20 Analysis and Commentary 1/17/20 Hill Day and Other Upcoming Alliance Advocacy Initiatives Read More
Analysis and Commentary 12/20/19 Analysis and Commentary 12/20/19 Success Again in 2019 ... Building Support for 2020 Read More
Analysis and Commentary 12/16/19 Analysis and Commentary 12/16/19 FDA's "Appropriation Fate" Is Evaluated on a Daily Basis Read More
Analysis and Commentary 12/8/19 Analysis and Commentary 12/8/19 Three Key Questions ... and the Answers Read More
Analysis and Commentary 11/22/19 Analysis and Commentary 11/22/19 Time to Talk Turkey ... Once Again Read More
